Project Grant HT94252510802
Award Date
7/15/25
Completion Date
7/14/28
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Awardee
Mayo Clinic (Y2K4F9RPRRG7)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
The Defense Health Agency awarded a $2,455,718 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Mayo Clinic in Rochester, Minnesota. The grant supports the "NKG7-Armed Tumor-Infiltrating Lymphocyte Therapy for Metastatic Uveal Melanoma" research project, with a performance period from September 1, 2025 to August 31, 2029. The grant funding will enable the Mayo Clinic, a renowned non-profit academic medical center, to conduct advanced...
The Defense Health Agency awarded Mayo Clinic Jacksonville $3,232,027 under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2023 through September 14, 2027. Through this award, Mayo Clinic will integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for service members...
The Defense Health Agency awarded a $597,543.00 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, a nonprofit academic medical center. The grant, which runs from October 1, 2023 to September 14, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420) to support research aimed at "elucidating mechanisms of CAR-T cell immunotherapy resistance and sensitivity to improve treatment of myeloma." As a nonprofit organization with...
The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...
This Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The $424,565 award to Mayo Clinic, a renowned non-profit academic medical center, will fund research to investigate the clinical significance of somatic genetic variants in telomere biology disorders over a 3-year period...
The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...
This federal Project Grant award of $1,782,155.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Mayo Clinic to identify novel drug targets for lethal prostate cancer using liquid biopsy techniques. The award period runs from April 1, 2025 to March 31, 2028. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations...
Mayo Clinic was awarded a $8,966,819 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2027 to further develop purified exosome products for treating pulmonary damage from toxic exposures, leveraging Mayo Clinic's expertise in exosome applications. Through this funding, Mayo Clinic aims to advance biomedical solutions applicable to both military and civilian...
The Defense Health Agency has awarded a $723,991 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic Jacksonville (A Nonprofit Corporation), doing business as Scott Lynch MD, located in Jacksonville, Florida. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium," will fund research to transform healthcare for military service members and the public through innovative and impactful cancer...
The Department of Defense's Defense Health Agency awarded a $322,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic in Rochester, Minnesota. The grant, with a performance period from April 1, 2024 to March 31, 2026, supports research on "MYELOPEROXIDASE PROMOTES PERSISTENT FIBROSIS." As a renowned non-profit academic medical center, Mayo Clinic will leverage its expertise in clinical care, biomedical research, and medical...